查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599337

维生素 D 治疗市场：途径、购买模式、年龄层、适应症分类 - 2025-2030 年全球预测

Vitamin D Therapy Market by Route of Administration (Oral Route of Administration, Parenteral Route of Administration), Purchasing Pattern (Over-The-Counter Drugs, Prescription Drugs), Age Group, Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

维生素D治疗市场2023年估值为32亿美元，预计2024年将达36.1亿美元，复合年增长率为12.75%，预计到2030年将达到74.2亿美元。

维生素 D 疗法包括使用维生素 D 来预防和治疗维生素 D 缺乏症和相关健康状况，例如骨质疏鬆症、佝偻病和某些自体免疫疾病。对维生素 D 的需求是显而易见的，因为它是维持骨骼健康和调节钙和磷吸收的基本身体需求。应用包括营养食品、强化食品、处方药和日光浴，最终用途包括阳光照射有限、饮食不足和某些健康状况的人。主要市场成长要素包括由于人口老化导致的骨骼相关疾病风险增加、由于现代室内生活方式导致维生素 D 缺乏症盛行率增加以及人们认识到维生素 D 的健康益处。新的商机包括开发个人化维生素 D 疗法、满足客製化的健康需求以及探索新的递送方法，例如提高生物利用度和功效的奈米製剂。利用这些机会的建议包括投资创新产品线的研发以及利用与医疗保健提供者的伙伴关係来教育消费者。然而，维生素 D 市场面临着局限性和挑战，包括维生素 D 毒性风险（尤其是在高剂量监管下）、补充品核准的监管障碍以及来自替代疗法的竞争。此外，由于新兴市场对补充品功效的认识不足和怀疑，市场成长可能会放缓。最佳创新领域包括研究维生素 D 的基因相关反应、针对缺乏症的非侵入性诊断工具以及针对营养高风险族群的强化食品。该市场是动态的，其特点是受科学进步和公共卫生趋势影响而具有稳定增长的潜力，并且需要灵活的商业策略来适应不断变化的消费者偏好和监管环境。

主要市场统计
基准年[2023] 32亿美元
预测年份 [2024] 36.1亿美元
预测年份 [2030] 74.2亿美元
复合年增长率（%） 12.75%

市场动态：揭示快速发展的维生素 D 治疗市场的关键市场洞察

供需的动态交互作用正在改变维生素 D 治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 美国维生素 D 缺乏症人数增加。
    • 存在大量目标患者群体
    • 人们对维生素 D 疗法的认识不断提高
  • 市场限制因素
    • 有限的临床试验
  • 市场机会
    • 营养不良发生率高的国家的成长机会增加
    • 活性化研发活动以有效开发维生素 D 疗法
  • 市场挑战
    • 强化食品的供应

波特五力：驾驭维生素 D 治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解维生素 D 治疗市场的外部影响

外部宏观环境因素在塑造维生素 D 治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解维生素 D 治疗市场的竞争模式

维生素 D 治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵维生素 D 治疗市场供应商的绩效评估

FPNV 定位矩阵是评估维生素 D 治疗市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了维生素 D 治疗市场的成功之路

维生素 D 治疗市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 美国维生素 D 缺乏症呈上升趋势
      • 目标患者群广泛
      • 提高维生素 D 疗法的认识
    • 抑制因素
      • 有限的临床试验
    • 机会
      • 扩大营养不足发生率高的国家的成长机会
      • 增加研发活动以开发有效的维生素 D 疗法
    • 任务
      • 强化食品的供应
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章维生素 D 治疗市场：依给药途径

  • 口服给药
  • 肠胃外给药途径

第七章维生素D治疗市场（按购买模式）

  • 非处方药
  • 处方药

第八章维生素 D 治疗市场：依年龄组

  • 成人
  • 孩子们

第九章维生素 D 治疗市场（按适应症）

  • 自体免疫疾病
  • 肌肉无力
  • 骨质疏鬆症
  • 疳
  • 皮肤病

第10章美洲维生素D治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太维生素D治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲维生素D治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Amway Corp.
  • Bayer AG
  • Bio-Tech Pharmacal, Inc.
  • GlaxoSmithKline PLC
  • Healthy Body LLC
  • Merck KGaA
  • Otsuka Holdings Co., Ltd
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Superior Supplement Manufacturing
  • The Zydus group
  • Vitablend Nederland BV
Product Code: MRR-4302AC721F94

The Vitamin D Therapy Market was valued at USD 3.20 billion in 2023, expected to reach USD 3.61 billion in 2024, and is projected to grow at a CAGR of 12.75%, to USD 7.42 billion by 2030.

Vitamin D therapy encompasses the use of vitamin D to prevent or treat deficiency and associated health conditions, including osteoporosis, rickets, and certain autoimmune diseases. Its necessity is underscored by the body's vital requirement for maintaining healthy bones and regulating calcium and phosphorus absorption. Application areas include dietary supplements, fortified foods, prescription medications, and sunlight exposure, with end-use spanning individuals with limited sun exposure, dietary deficiencies, and specific health conditions. Key market growth factors include an aging population more at risk for bone-related ailments, increasing prevalence of vitamin D deficiency due to modern indoor lifestyles, and growing awareness about the health benefits of vitamin D. Moreover, rising healthcare expenditures and advancements in vitamin D formulations further propel market demand. Emerging opportunities include the development of personalized vitamin D therapy, addressing tailored health needs, and exploring new delivery methods, like nanoscale formulations, for enhanced bioavailability and efficacy. Recommendations to capitalize on these opportunities include investing in R&D for innovative product lines and leveraging partnerships with healthcare providers to educate consumers. However, the market faces limitations and challenges such as risks of vitamin D toxicity, particularly in unsupervised, high-dose consumption, regulatory hurdles related to supplement approvals, and competition from alternative therapies. Furthermore, market growth could be slowed by a lack of awareness in developing regions and skepticism over supplementation benefits. Best areas of innovation include research on gene-related responses to vitamin D, non-invasive diagnostic tools for deficiency, and fortified foods targeting nutritionally at-risk populations. The market is dynamic, characterized by steady growth potential influenced by scientific advancements and public health trends, necessitating agile business strategies to adapt to evolving consumer preferences and regulatory landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 3.20 billion
Estimated Year [2024] USD 3.61 billion
Forecast Year [2030] USD 7.42 billion
CAGR (%) 12.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vitamin D Therapy Market

The Vitamin D Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of vitamin D deficiency in the U.S.
    • Presence of a large target patient population
    • Growing awareness regarding vitamin D therapy
  • Market Restraints
    • Limited clinical Trials
  • Market Opportunities
    • Increasing growth opportunities in countries with a high prevalence of undernutrition
    • Rise in R&D activities for development of efficient vitamin D therapies
  • Market Challenges
    • Availability of fortified foods

Porter's Five Forces: A Strategic Tool for Navigating the Vitamin D Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vitamin D Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vitamin D Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vitamin D Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vitamin D Therapy Market

A detailed market share analysis in the Vitamin D Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vitamin D Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vitamin D Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vitamin D Therapy Market

A strategic analysis of the Vitamin D Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vitamin D Therapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alkem Laboratories Ltd., Amway Corp., Bayer AG, Bio-Tech Pharmacal, Inc., GlaxoSmithKline PLC, Healthy Body LLC, Merck KGaA, Otsuka Holdings Co., Ltd, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Superior Supplement Manufacturing, The Zydus group, and Vitablend Nederland B.V..

Market Segmentation & Coverage

This research report categorizes the Vitamin D Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Oral Route of Administration and Parenteral Route of Administration.
  • Based on Purchasing Pattern, market is studied across Over-The-Counter Drugs and Prescription Drugs.
  • Based on Age Group, market is studied across Adults and Children.
  • Based on Indication, market is studied across Autoimmune Disorders, Muscle Weakness, Osteoporosis, Rickets, and Skin Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of vitamin D deficiency in the U.S.
      • 5.1.1.2. Presence of a large target patient population
      • 5.1.1.3. Growing awareness regarding vitamin D therapy
    • 5.1.2. Restraints
      • 5.1.2.1. Limited clinical Trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing growth opportunities in countries with a high prevalence of undernutrition
      • 5.1.3.2. Rise in R&D activities for development of efficient vitamin D therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of fortified foods
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vitamin D Therapy Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Oral Route of Administration
  • 6.3. Parenteral Route of Administration

7. Vitamin D Therapy Market, by Purchasing Pattern

  • 7.1. Introduction
  • 7.2. Over-The-Counter Drugs
  • 7.3. Prescription Drugs

8. Vitamin D Therapy Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adults
  • 8.3. Children

9. Vitamin D Therapy Market, by Indication

  • 9.1. Introduction
  • 9.2. Autoimmune Disorders
  • 9.3. Muscle Weakness
  • 9.4. Osteoporosis
  • 9.5. Rickets
  • 9.6. Skin Diseases

10. Americas Vitamin D Therapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vitamin D Therapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vitamin D Therapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alkem Laboratories Ltd.
  • 3. Amway Corp.
  • 4. Bayer AG
  • 5. Bio-Tech Pharmacal, Inc.
  • 6. GlaxoSmithKline PLC
  • 7. Healthy Body LLC
  • 8. Merck KGaA
  • 9. Otsuka Holdings Co., Ltd
  • 10. Pfizer Inc.
  • 11. Sanofi S.A.
  • 12. Sun Pharmaceutical Industries Ltd.
  • 13. Superior Supplement Manufacturing
  • 14. The Zydus group
  • 15. Vitablend Nederland B.V.

LIST OF FIGURES

  • FIGURE 1. VITAMIN D THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. VITAMIN D THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VITAMIN D THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VITAMIN D THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2023